免疫疗法增强的立体性废除性放射治疗在不可手术的早期非小细胞肺癌中
Jie Lian1, Li Sun1, Shuling Zhang1
1Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, China.
Current treatment options in oncology
|May 8, 2025
概括
与免疫检查点抑制剂 (iSABR) 结合的立体性废除性放射治疗 (SABR) 显示,早期非小细胞肺癌 (NSCLC) 的无进展生存率得到改善. 这种组合疗法提供了潜在的好处与可管理的风险.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 早期,不可手术的非小细胞肺癌 (NSCLC) 提出了治疗挑战.
- 立体性除性放射疗法 (SABR) 是一种标准的治疗选择.
- 免疫检查点抑制剂与SABR (iSABR) 的整合是一种新兴的治疗策略.
研究的目的:
- 为了评估iSABR的疗效和安全性与SABR单独相比,在早期,不可操作的NSCLC中.
- 分析无进展生存 (PFS) 和整体生存 (OS) 的结果.
- 确定可能从iSABR中受益最多的患者子组.
主要方法:
- 进行了对7项涉及462名患者的研究的元分析.
- 在iSABR和SABR组之间比较了无进展生存率 (PFS) 和整体生存率 (OS).
- 根据特定的免疫检查点抑制剂和辐射剂量进行了子组分析.
主要成果:
- 与单独使用SABR相比,iSABR显著改善了1年,2年和3年的PFS率.
- 通过iSABR观察到改善整体存活 (OS) 的趋势.
- 通过编程死亡-1 (PD-1) 抑制剂和更高的辐射剂量 (≥12.5 Gy) 观察到增强的3年PFS.
- 观察到≥3级不良事件的轻微增加,如肺炎和疲劳,但被认为是可控的.
结论:
- 在早期,不可操作的NSCLC中,iSABR显示出有希望的疗效,改善了PFS和可接受的毒性.
- 这些发现支持iSABR作为一种潜在的治疗选择,需要进一步调查.
- 需要III期随机对照试验来确认疗效,优化方案,并确定长期的安全性.
更多相关视频
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.1K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
01:27Tumor Immunotherapy
401
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
401
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K